

NAD+
Description
Recharge Your Cells and Support Longevity with Alfa Vitamins NAD+ Plus Resveratrol. This advanced formula is designed to support healthy aging, mitochondrial function, and cellular resilience by combining four synergistic ingredients: N-Acetyl-L-Cysteine (NAC), Nicotinamide Riboside Hydrogen Malate, NAD (B-Nicotinamide Adenine Dinucleotide), and Resveratrol from Polygonum cuspidatum.
NAC is a precursor to glutathione, a critical intracellular antioxidant that protects against oxidative stress, supports detoxification, and enhances immune and cognitive function. Nicotinamide Riboside Hydrogen Malate, a bioavailable form of vitamin B3, promotes the body's natural production of NAD+ a coenzyme essential for energy metabolism and DNA repair. Supplementing directly with NAD further sustains mitochondrial performance and cellular function under stress. Resveratrol, a potent polyphenol, offers strong antioxidant and anti-inflammatory support, promotes cardiovascular health, and activates sirtuins, proteins linked to longevity and cellular repair. Together, these ingredients help optimize cellular energy, reduce oxidative damage, and promote long-term vitality and wellness.
- Cellular longevity support: Resveratrol is a polyphenol studied for its role in cellular stress response and pathways associated with aging (sirtuin activation shown in preclinical research).
- Mitochondrial & energy metabolism: Supports processes involved in cellular energy production and resilience under stress.
- Boosts NAD+ levels: Nicotinamide Riboside, a bioavailable form of Vitamin B3, supports the body's natural NAD+ production, involved in metabolism and DNA repair.
- Antioxidant support: Resveratrol contributes antioxidant activity that helps counter oxidative stress.
NAD+ is a coenzyme involved in cellular energy metabolism. This formula pairs NAD+ with resveratrol and a third label-listed ingredient, nicotinamide ribose.
- 600 mg NAD+ per three-capsule serving
- 100 mg resveratrol per serving

This product has no reviews yet.